Sun, Dec 28, 2014, 1:04 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • npa_nt npa_nt Nov 12, 2013 10:40 AM Flag

    FDA WANTS MORE TESTINGS...SRPT Will Have To Go Thru It !

    They did not reject the drug !!! More testing need to be done. And SRPT will have to go thru Phase 3, and they will prove Etep works. Not many company out there can gain AA status, especially dealing with the deadly disease. Hang tough. I will NOT sell a single share ! Long at 37.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Lost of insider buying prior to news. I think they planed on approval. On the flip I agree with you and this is something we have to allow to take a little nap until the y smoothe out the wrinkles. Patience is very much Key here and it will be a great thing for all when this MS drug is approved!!!! I am going to buy a little more as the dust settles.

      Sentiment: Buy

    • regulatoryexpert@att.net regulatoryexpert Nov 12, 2013 10:49 AM Flag

      yes, I agree you need more testing like proof of concept phase 2 trial with at least 50 patients prior to investing in expensive phase III trial before every knuckle head invests in this POS stock.

 
SRPT
13.92+0.04(+0.29%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.